Scribe Therapeutics Presents New Data Advancing the Potential of Ultra-Long-Acting Genetic Medicines for Cardiovascular Disease at AHA Scientific Sessions 2026
Scribe Therapeutics presents new data advancing the potential of ultra-long-acting genetic medicines for cardiovascular disease at AHA Scientific Sessions